Sun Pharma to sell AstraZeneca's Type 2 diabetes medicine in India
Sun Pharmaceutical Industries has entered a partnership with AstraZeneca to sell the latter's Type 2 diabetes (T2D) medicine, dapagliflozin, in India.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news
More News: AstraZeneca | Dapagliflozin | Diabetes | Diabetes Type 2 | Endocrinology | Forxiga | Partnerships | Pharmaceuticals